Clinical trials recruiting in Longyan, China

Phase breakdown

Conditions recruiting in Longyan, China

Recruiting trials in Longyan, China

• A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
  NCT07010263 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
  NCT07136792 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female)
• ASPIrin in Reducing Events in Dialysis ( ASPIRED )
  NCT04381143 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
  NCT07607275 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Longyan, China?

4 recruiting trials have at least one study site in Longyan, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.